Abbott Laboratories (CHIX:ABLD) Net Change in Cash : €220 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Abbott Laboratories Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Abbott Laboratories's Net Change in Cash for the three months ended in Mar. 2025 was €-1,003 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was €220 Mil.

Abbott Laboratories Net Change in Cash Historical Data

The historical data trend for Abbott Laboratories's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Net Change in Cash Chart

Abbott Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

2,447.92

2,620.49

78.35

-2,738.16

687.60

Abbott Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-563.04	653.09	514.47	55.39	-1,002.70

Abbott Laboratories Net Change in Cash Calculation

Abbott Laboratories's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	8172.89	+	-2232.79	+	-5160.82	+	-91.68
	=	688

Abbott Laboratories's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 1310.725 + -434.75 + -1900.875 + 22.2

= -1,003

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €220 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Abbott Laboratories's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (CHIX:ABLd) » Definitions » Net Change in Cash

Comparable Companies

BSX SYK MDT EW DXCM STE ZBH PODD PEN GMED XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 TSE:7733 TSE:6869 LSE:SN. ASX:COH MASI

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories Headlines